Girard M - Search Results

1

Processing, stability, and receptor binding properties of oligomeric envelope glycoprotein from a primary HIV-1 isolate.

Staropoli I, Chanel C, Girard M, Altmeyer R. Staropoli I, et al. Among authors: girard m. J Biol Chem. 2000 Nov 10;275(45):35137-45. doi: 10.1074/jbc.M003868200. J Biol Chem. 2000. PMID: 10926931 Free article.

2

Antibodies to several conformation-dependent epitopes of gp120/gp41 inhibit CCR-5-dependent cell-to-cell fusion mediated by the native envelope glycoprotein of a primary macrophage-tropic HIV-1 isolate.

Verrier FC, Charneau P, Altmeyer R, Laurent S, Borman AM, Girard M. Verrier FC, et al. Among authors: girard m. Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9326-31. doi: 10.1073/pnas.94.17.9326. Proc Natl Acad Sci U S A. 1997. PMID: 9256481 Free PMC article.

3

Expression and detection of macrophage-tropic HIV-1 gp120 in the brain using conformation-dependent antibodies.

Altmeyer R, Mordelet E, Girard M, Vidal C. Altmeyer R, et al. Among authors: girard m. Virology. 1999 Jul 5;259(2):314-23. doi: 10.1006/viro.1999.9780. Virology. 1999. PMID: 10388656 Free article.

4

Attenuated Mengo virus as a vector for immunogenic human immunodeficiency virus type 1 glycoprotein 120.

Altmeyer R, Escriou N, Girard M, Palmenberg A, van der Werf S. Altmeyer R, et al. Among authors: girard m. Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9775-9. doi: 10.1073/pnas.91.21.9775. Proc Natl Acad Sci U S A. 1994. PMID: 7937890 Free PMC article.

5

New prospects for the development of a vaccine against human immunodeficiency virus type 1. An overview.

Girard M, Habel A, Chanel C. Girard M, et al. C R Acad Sci III. 1999 Nov;322(11):959-66. doi: 10.1016/s0764-4469(00)87193-0. C R Acad Sci III. 1999. PMID: 10646090 Review.

6

The use of picornaviruses as vectors for the engineering of live recombinant vaccines.

Girard M, Altmeyer R, van der Werf S, Wychowski C, Martin A. Girard M, et al. Biologicals. 1995 Jun;23(2):165-9. doi: 10.1006/biol.1995.0027. Biologicals. 1995. PMID: 7546659 Review. No abstract available.

7

Study of the immunogenicity of different recombinant Mengo viruses expressing HIV1 and SIV epitopes.

Van der Ryst E, Nakasone T, Habel A, Venet A, Gomard E, Altmeyer R, Girard M, Borman AM. Van der Ryst E, et al. Among authors: girard m. Res Virol. 1998 Jan-Feb;149(1):5-20. doi: 10.1016/s0923-2516(97)86896-3. Res Virol. 1998. PMID: 9561560

8

DNA vaccine protection against challenge with simian/human immunodeficiency virus 89.6 in rhesus macaques.

Habel A, Chanel C, Le Grand R, Martinon F, Couillin L, Moog C, Doms R, Gauduin MC, Hurtrel B, Guillet JG, Aubertin AM, Girard M. Habel A, et al. Among authors: girard m. Dev Biol (Basel). 2000;104:101-5. Dev Biol (Basel). 2000. PMID: 11713807

9

Attenuated Mengo virus: a new vector for live recombinant vaccines.

Altmeyer R, Girard M, van der Werf S, Mimic V, Seigneur L, Saron MF. Altmeyer R, et al. Among authors: girard m. J Virol. 1995 May;69(5):3193-6. doi: 10.1128/JVI.69.5.3193-3196.1995. J Virol. 1995. PMID: 7707549 Free PMC article.

10

Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage.

Verrier F, Borman AM, Brand D, Girard M. Verrier F, et al. Among authors: girard m. AIDS Res Hum Retroviruses. 1999 May 20;15(8):731-43. doi: 10.1089/088922299310827. AIDS Res Hum Retroviruses. 1999. PMID: 10357469

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,825 results

Search Page

Filters